Akero Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Akero Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Akero Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$81.7M, a 75.3% decline year-over-year.
  • Akero Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$269M, a 97.4% decline year-over-year.
  • Akero Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$173M, a 50.1% decline from 2022.
  • Akero Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$115M, a 14.1% decline from 2021.
  • Akero Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$101M, a 25.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$173M -$57.7M -50.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$115M -$14.3M -14.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$101M -$20.7M -25.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$80.2M -$34.5M -75.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
2019 -$45.7M -$31.9M -231% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 -$13.8M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.